We recently compiled a list of the 10 Popular Penny Stocks on Robinhood to Watch in 2026.
Lucid Diagnostics Inc. (NASDAQ:LUCD) is also on this list of popular penny stocks
TheFly reported on May 15 that Maxim Group reduced its price target on LUCD from $3 to $2 while maintaining a Buy rating following a weaker-than-expected first-quarter revenue report. The company continues to await a Medicare local coverage determination decision, but is actively advancing its commercialization strategy in preparation for potential reimbursement approval, according to the analyst note. Lucid Diagnostics Inc. (NASDAQ:LUCD) issued its first-quarter 2026 financial results on May 14, alongside a broader business update for the period ended March 31, 2026.
The company reported $1.3 million in revenue generated from EsoGuard esophageal DNA testing, based on 3,177 tests processed during the quarter. Operating expenses totaled approximately $13.4 million, including $1.4 million in stock-based compensation, resulting in a GAAP net loss of about $23.6 million attributable to common shareholders. On a non-GAAP basis, adjusted loss was approximately $10.5 million.